Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Walgaard C, et al. Among authors: wohlgemuth m. Lancet Neurol. 2021 Apr;20(4):275-283. doi: 10.1016/S1474-4422(20)30494-4. Epub 2021 Mar 17. Lancet Neurol. 2021. PMID: 33743237 Clinical Trial.
Strength training and albuterol in facioscapulohumeral muscular dystrophy.
van der Kooi EL, Vogels OJ, van Asseldonk RJ, Lindeman E, Hendriks JC, Wohlgemuth M, van der Maarel SM, Padberg GW. van der Kooi EL, et al. Among authors: wohlgemuth m. Neurology. 2004 Aug 24;63(4):702-8. doi: 10.1212/01.wnl.0000134660.30793.1f. Neurology. 2004. PMID: 15326246 Clinical Trial.
Respiratory function in facioscapulohumeral muscular dystrophy 1.
Wohlgemuth M, Horlings CGC, van der Kooi EL, Gilhuis HJ, Hendriks JCM, van der Maarel SM, van Engelen BGM, Heijdra YF, Padberg GW. Wohlgemuth M, et al. Neuromuscul Disord. 2017 Jun;27(6):526-530. doi: 10.1016/j.nmd.2017.03.008. Epub 2017 Mar 22. Neuromuscul Disord. 2017. PMID: 28416348
[Ocular myasthenia gravis: diagnosis often delayed].
van den Berg B, Wohlgemuth M, Tijssen CC. van den Berg B, et al. Among authors: wohlgemuth m. Ned Tijdschr Geneeskd. 2011;155(33):A3241. Ned Tijdschr Geneeskd. 2011. PMID: 21854656 Dutch.
No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy.
van der Kooi EL, de Greef JC, Wohlgemuth M, Frants RR, van Asseldonk RJ, Blom HJ, van Engelen BG, van der Maarel SM, Padberg GW. van der Kooi EL, et al. Among authors: wohlgemuth m. Neuromuscul Disord. 2006 Nov;16(11):766-9. doi: 10.1016/j.nmd.2006.08.005. Epub 2006 Sep 26. Neuromuscul Disord. 2006. PMID: 17005397 Free article.
Dysphagia in facioscapulohumeral muscular dystrophy.
Wohlgemuth M, de Swart BJ, Kalf JG, Joosten FB, Van der Vliet AM, Padberg GW. Wohlgemuth M, et al. Neurology. 2006 Jun 27;66(12):1926-8. doi: 10.1212/01.wnl.0000219760.76441.f8. Neurology. 2006. PMID: 16801662 Clinical Trial.
73 results